Sanofi weighing takeover of US drugmaker Insmed, Bloomberg reports
Life Sciences
Thursday, November 19, 2026
- Updated Nov 19, 2026 10:41
Sanofi is weighing an acquisition of US drugmaker Insmed, Bloomberg News reported on Thursday, citing people familiar with the matter, according to Reuters.
Why it matters: A Sanofi bid would put a large French drugmaker in play for a US respiratory specialist, but the report is unconfirmed, names no terms, and neither company has announced an agreement.
Data as of Reuters brief of November 19, 2026 reporting Bloomberg News, read in full via a syndicated copy after Bloomberg itself was blocked to this reader; single-source, unconfirmed report citing unnamed people familiar with the matter. Developing item.
Sanofi is weighing an acquisition of US drugmaker Insmed, Bloomberg News reported on Thursday, citing people familiar with the matter, Reuters reported on November 19. The report gave no price or terms.
Neither company has announced an agreement, and the report rests on unnamed sources, so it ships as an unconfirmed developing item.
Sources
- Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports - Reuters - 2026-11-19